Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NeuCyte
AddedFeb 15, 2024
UpdatedJun 18, 2026
NeuCyte

NeuCyte

Series A

Neucyte, Inc.: A US-based bio-pharmaceutical firm specializing in cell-based neurological drug discovery.

HQ
Mountain View, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded in San Carlos, CA, NeuCyte, Inc. is a pioneering bio-pharmaceutical company dedicated to developing innovative drugs for neurological diseases. The company’s core mission is to advance the understanding and treatment of neurological disorders through cutting-edge cell-based drug discovery. NeuCyte offers specialized products and services, including their proprietary SynFire® technology, which facilitates long-term functional characterization of induced neurons (iNs) and astrocytes. Their market focus primarily includes pharmaceutical companies and research institutions in the United States.

NeuCyte has garnered attention for its notable team of experts in neuroscience and drug discovery. The company has achieved significant milestones, including the successful application of their SynFire® technology in high-density microelectrode arrays, enhancing the precision and efficacy of neurological drug testing. With a strong emphasis on scientific discovery and innovation, NeuCyte has made a substantial impact on the field of neuropharmacology, contributing valuable insights and tools for the development of treatments for neurological diseases.

NeuCyte - Similar Companies

Neurana Pharmaceuticals logo

Neurana Pharmaceuticals

neuranapharma.com

NeyroblastGX logo

NeyroblastGX

neyroblastgx.com

Neurovia logo

Neurovia

Neuraly logo

Neuraly

neuralymed.com

NeuroCytonix logo

NeuroCytonix

neurocytonix.com

jCyte logo

jCyte

jcyte.com

Neurona Therapeutics logo

Neurona Therapeutics

EyeCyte logo

EyeCyte

eyecyte.com

BrainXell logo

BrainXell

brainxell.com

Neurogene logo

Neurogene

neurogene.com

Cytocybernetics logo

Cytocybernetics

NeuroX1 logo

NeuroX1

neurox1.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Stem Pharm logo

Stem Pharm

stempharm.com

PharmaCyte Biotech logo

PharmaCyte Biotech

pharmacyte.com

NeuCyte - Quick Facts

Who are NeuCyte's competitors?

Companies similar to NeuCyte include Neurana Pharmaceuticals, NeyroblastGX, Neurovia and Neuraly.

When was NeuCyte founded?

NeuCyte was founded in 2015.

Where is NeuCyte's headquarters located?

NeuCyte's headquarters is located in Mountain View, CA, US.

When was NeuCyte's last funding round?

NeuCyte's most recent funding round was for $6.7M (USD) in May 2018.

How much has NeuCyte raised to-date?

As of May 8, 2018, NeuCyte has raised a total of $6.7M (USD).

How many employees does NeuCyte have?

NeuCyte has 11 employees as of Feb 4, 2024.

NeuCyte - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified